Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial

This publication has 23 references indexed in Scilit:

• Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography
  Journal of the American College of Cardiology, 1989
• Importance of effective, early and sustained reperfusion during acute myocardial infarction
  The American Journal of Cardiology, 1989
• Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: Results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial
  Journal of the American College of Cardiology, 1989
• Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?
  Circulation, 1989
• The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction
  The American Journal of Cardiology, 1988
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survival
  Journal of the American College of Cardiology, 1988
• Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
  New England Journal of Medicine, 1983
• Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction.
  Journal of Clinical Investigation, 1983
• Effects of spontaneous and streptokinase-induced recanalization on left ventricular function after myocardial infarction.
  Circulation, 1983